2017 Annual Meeting | C72 - Gender-specific Care for Neurological Disorders
07:00 AM - 07:10 AM | Luncheon |
Introduction
Jennifer Graves, MD, PhD |
07:10 AM - 07:40 AM | Speaker |
Gender-based Care Considerations in Multiple Sclerosis
Jennifer Graves, MD, PhD |
07:40 AM - 08:10 AM | Speaker |
Neuroendocrine Considerations in the Treatment of Men and Women with Epilepsy
Cynthia L. Harden, MD |
08:10 AM - 08:40 AM | Speaker |
Gender-based Care in Neurovascular Diseases
Vineeta Singh, MD, FAAN |
08:40 AM - 09:00 AM | Q&A |
Questions and Answers
|
Jennifer Graves, MD, PhD | Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono. |
Cynthia L. Harden, MD | Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care. |
Vineeta Singh, MD, FAAN | Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genae Americas, Inc. . |